Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Detalles Bibliográficos
Autores principales: Peleg Hasson, S., Brezis, M.R., Shachar, E., Shachar, S.S., Wolf, I., Sonnenblick, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233645/
https://www.ncbi.nlm.nih.gov/pubmed/34144779
http://dx.doi.org/10.1016/j.esmoop.2021.100158
_version_ 1783713899782078464
author Peleg Hasson, S.
Brezis, M.R.
Shachar, E.
Shachar, S.S.
Wolf, I.
Sonnenblick, A.
author_facet Peleg Hasson, S.
Brezis, M.R.
Shachar, E.
Shachar, S.S.
Wolf, I.
Sonnenblick, A.
author_sort Peleg Hasson, S.
collection PubMed
description
format Online
Article
Text
id pubmed-8233645
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82336452021-06-29 Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] Peleg Hasson, S. Brezis, M.R. Shachar, E. Shachar, S.S. Wolf, I. Sonnenblick, A. ESMO Open Erratum Elsevier 2021-06-16 /pmc/articles/PMC8233645/ /pubmed/34144779 http://dx.doi.org/10.1016/j.esmoop.2021.100158 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Peleg Hasson, S.
Brezis, M.R.
Shachar, E.
Shachar, S.S.
Wolf, I.
Sonnenblick, A.
Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
title Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
title_full Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
title_fullStr Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
title_full_unstemmed Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
title_short Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]
title_sort erratum to ‘adjuvant endocrine therapy in her2-positive breast cancer patients: systematic review and meta-analysis’: [esmo open volume 6, issue 2, april 2021, 100088]
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233645/
https://www.ncbi.nlm.nih.gov/pubmed/34144779
http://dx.doi.org/10.1016/j.esmoop.2021.100158
work_keys_str_mv AT peleghassons erratumtoadjuvantendocrinetherapyinher2positivebreastcancerpatientssystematicreviewandmetaanalysisesmoopenvolume6issue2april2021100088
AT brezismr erratumtoadjuvantendocrinetherapyinher2positivebreastcancerpatientssystematicreviewandmetaanalysisesmoopenvolume6issue2april2021100088
AT shachare erratumtoadjuvantendocrinetherapyinher2positivebreastcancerpatientssystematicreviewandmetaanalysisesmoopenvolume6issue2april2021100088
AT shacharss erratumtoadjuvantendocrinetherapyinher2positivebreastcancerpatientssystematicreviewandmetaanalysisesmoopenvolume6issue2april2021100088
AT wolfi erratumtoadjuvantendocrinetherapyinher2positivebreastcancerpatientssystematicreviewandmetaanalysisesmoopenvolume6issue2april2021100088
AT sonnenblicka erratumtoadjuvantendocrinetherapyinher2positivebreastcancerpatientssystematicreviewandmetaanalysisesmoopenvolume6issue2april2021100088

Ejemplares similares